The latest biotech news

News and Trends 24 Nov 2015

Money Money Money for Immuno-Oncology: BMS Joins up with a Top German VC

The World Leader in the Immuno-Oncology field has teamed up with a major German Investor to better identify breakthrough investment opportunities across the EU. Bristol-Myers Squibb (BMS) has partnered with Life Sciences Partners in Munich to highlight novel immuno-oncology technologies which could be the next blockbusters in the field. Together the two have conspired a […]

November 24, 2015 - 2 minutesmins - By Dani Bancroft

News and Trends 24 Nov 2015

2015 Review: What Exciting Developments Have Been Made in Neurodegenerative Disease?

Since both Alzheimer’s Disease and Parkinson’s combined affect up to 50 million people worldwide, it is no wonder this new wave of break-through milestones is getting the industry excited… The Central Nervous System (CNS) comprises many complex tissues and highly specialized cell types, mutation in which can cause an array of deadly and chronic diseases. […]

November 24, 2015 - 9 minutesmins - By Dani Bancroft

News and Trends 24 Nov 2015

Next Generation Sequencing: the final step to massively adopt Personalized Medicine

For several decades, physicians have been dreaming of a Personalized Medicine, able to treat patients according to their genetic profile. The development of Next Generation Sequencing techniques can be the ultimate step before a massive adoption of personalized medicine. The world of medicine is shifting from the traditional “one size fits all” approach to one […]

November 24, 2015 - 4 minutesmins - By Joachim Eeckhout

News and Trends 23 Nov 2015

Finally, Pfizer acquires Botox-maker Allergan for €150Bn to move to tax-friendly Ireland!

The Rumor became more and more tangleon what is now the biggest Pharma deal ever. The Rumor was pumped up by reports from Bloomberg and CNBC, saying the deal could be closed on Monday, as we reported here. And now it’s official. Just a few hours ago, Pfizer announced it agrees on buying Allergan for €150Bn […]

November 23, 2015 - 1 minutemin - By Philip Hemme

News and Trends 23 Nov 2015

Making Propane From Gut-Bacteria: A UK-Finland Team Want to Say Ciao to Fracking

Five genes introduced in the bacterial genome of E.coli can modify its metabolism to synthesise propane, which can be then converted to liquified petroleum gas (LPG) as an alternative source of fuel. Escherichia coli is a facultative anaerobe of the genus Escherichia that is commonly found in the lower intestine. An international team of researchers […]

November 23, 2015 - 3 minutesmins - By Joachim Eeckhout

News and Trends 21 Nov 2015

What happened this week? Genfit, History of Biotech, Cellectis

Monday: Interview with the CEO of Genfit – The Billion Euro Liver Biotech on its phase III NASH Drug Tuesday: History of Biotech: How Modern Biotechnology Started-Up 39 Years Ago Wednesday: The UK Catapults Cell Therapy Manufacture into Europe with a €78.5M New Facility Thursday: Why has the Universal CAR-T Treatment For Leukemia Hooked TWO Big Pharmas […]

November 21, 2015 - 1 minutemin - By Philip Hemme

women in biotech movers shakers 2015 biobeats

News and Trends 20 Nov 2015

Get to Know the Top 50 Women in the UK’s Biotech Scene

The Movers & Shakers Report 2015 lists 50 of the Top female Bio-Entrepreneurs… here’s a select few I found particularly impressive in the Biotech Industry! Written by Miranda Weston-Smith, the BioBeat15 report is sponsored by Horton Ruston Poole, Johnson & Johnson Innovation, MedImmune and Pfizer to celebrate what women working in bio-business have brought to […]

November 20, 2015 - 5 minutesmins - By Dani Bancroft

News and Trends 20 Nov 2015

Cinfa Biotech’s Biosimilar is on the Starting Block!

Recently launched Cinfa Biotech just treated the first subjects in a clinical trial with its biosimilar of Neulasta®! Cinfa Biotech just announced that the first subjects have been dosed in a clinical trial of B12019, a biosimilar version of Amgen’s Neulasta® (pegfilgrastim) to treat chemotherapy-induced neutropenia. Though chemotherapy is highly effective against cancer, it is […]

November 20, 2015 - 4 minutesmins - By Joachim Eeckhout

News and Trends 20 Nov 2015

Biotech of the week: Opsona Therapeutics, The Leading Irish Immuno-Oncology Biotech

This week we say farewell to Austria and head North-West, across the United Kingdom and land in the Emerald Isle, Ireland, where we arrive at our destination, Dublin. The capital city of Ireland is the home of the very famous Irish dry stout, Trinity College (plus its stunning library) and a nearly 900-year-old cathedral. It is […]

November 20, 2015 - 2 minutesmins - By Philip Hemme

frits ahlefeldt cellectis servier pfizer ucart leukemia1

News and Trends 19 Nov 2015

Why has the Universal CAR-T Treatment For Leukemia Hooked TWO Big Pharmas at Once?

French Servier and Pfizer have already had independent partnerships with Cellectis on various R&D areas. But now the two have signed a joint partnership on Cellectis’s leading product UCART19 for blood cancer. This unusual move only further feeds the rumours of Pfizer’s potential future acquisition of Cellectis. As we’ve discussed before, Cellectis has moved most […]

November 19, 2015 - 3 minutesmins - By Dani Bancroft

News and Trends 19 Nov 2015

“The Next Generation of Biologicals will be Cell-based”

That’s what Zami Aberman, CEO of one of the world-leading cell-therapy company Pluristem told me during our lunch at Berlin this week. An enthusiastic statement for a sector that could indeed be the next blockbuster after the monoclonal antibodies. Pluristem is an Israel based Biotech company developing off-the-shelf cell therapies for a variety of human diseases. What makes […]

November 19, 2015 - 6 minutesmins - By Philip Hemme

News and Trends 19 Nov 2015

This 10,000 Employee French Pharma is Finally Entering the Biotech Partnership Race

Biotech is getting more and more about partnering rather than doing everything alone. Some conservative Pharmas, which worked to more of a ‘Silo model’, are now branching out in a more open approach; the last one being the Pharma company from the south-west of France Pierre Fabre. The company, named after its iconic founder Pierre Fabre, […]

November 19, 2015 - 3 minutesmins - By Philip Hemme

Resources

Categories

The twelve hottest biotech companies in the Boston area

Biotech bankruptcies: what to expect in 2024 following a record year?

Approaches

Therapeutic areas

RNA editing set to take off: could it outperform gene editing?

Future of cancer treatment: what will therapy look like in 2034?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The twelve hottest biotech companies in the Boston area

Biotech bankruptcies: what to expect in 2024 following a record year?

RNA editing set to take off: could it outperform gene editing?

Future of cancer treatment: what will therapy look like in 2034?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

News and Trends

Money Money Money for Immuno-Oncology: BMS Joins up with a Top German VC

2015 Review: What Exciting Developments Have Been Made in Neurodegenerative Disease?

Next Generation Sequencing: the final step to massively adopt Personalized Medicine

Finally, Pfizer acquires Botox-maker Allergan for €150Bn to move to tax-friendly Ireland!

Making Propane From Gut-Bacteria: A UK-Finland Team Want to Say Ciao to Fracking

What happened this week? Genfit, History of Biotech, Cellectis

Get to Know the Top 50 Women in the UK’s Biotech Scene

Cinfa Biotech’s Biosimilar is on the Starting Block!

Biotech of the week: Opsona Therapeutics, The Leading Irish Immuno-Oncology Biotech

Why has the Universal CAR-T Treatment For Leukemia Hooked TWO Big Pharmas at Once?

“The Next Generation of Biologicals will be Cell-based”

This 10,000 Employee French Pharma is Finally Entering the Biotech Partnership Race

Subscribe to our newsletter to get the latest biotech news!